1,298
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II

, , , &
Pages 208-213 | Received 26 Jun 2016, Accepted 04 Oct 2016, Published online: 23 Jan 2017

References

  • Gülçin İ, Beydemir Ş, Büyükokuroğlu ME. In vitro and in vivo effects of dantrolene on carbonic anhydrase enzyme activities. Biol Pharm Bull 2004;27:613–16.
  • Beydemir Ş, Gülçin İ. Effects of melatonin on carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo. J Enzyme Inhib Med Chem 2004;19:193–7.
  • Aras-Hisar Ş, Hisar O, Beydemir Ş, et al. Effect of vitamin E on carbonic anhydrase enzyme activity in rainbow trout (Oncorhynchus mykiss) erythrocytes in vitro and in vivo. Acta Vet Hung 2004;52:413–22.
  • Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 2011;10:767–77.
  • Marini AM, Maresca A, Aggarwal M, et al. Tricyclic sulfonamides incorporating benzothiopyrano[4,3-c]pyrazole and pyridothiopyrano[4,3-c]pyrazole effectively inhibit α- and β-carbonic anhydrase: X-ray crystallography and solution investigations on 15 isoforms. J Med Chem 2012;55:9619–29.
  • Topal M, Gülçin İ. Rosmarinic acid: a potent carbonic anhydrase isoenzymes inhibitor. Turk J Chem 2014;38:894–902.
  • Zimmerman SA, Ferry JG, Supuran CT. Inhibition of the archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases. Curr Top Med Chem 2007;7:901–18.
  • Çetinkaya Y, Göçer H, Gülçin İ, Menzek A. Synthesis and carbonic anhydrase isoenzymes inhibitory effects of brominated diphenylmethanone and its derivatives. Arch Pharm 2014;347:354–9.
  • Çetinkaya Y, Göçer H, Göksu S, Gülçin İ. Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives. J Enzyme Inhib Med Chem 2014;29:168–74.
  • Güney M, Coşkun A, Topal F, et al. Oxidation of cyanobenzocycloheptatrienes: synthesis, photooxygenation reaction and carbonic anhydrase isoenzymes inhibition properties of some new benzotropone derivatives. Bioorg Med Chem 2014;22:3537–43.
  • Nar M, Çetinkaya Y, Gülçin İ, Menzek A. (3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors. J Enzyme Inhib Med Chem 2013;28:402–6.
  • Hisar O, Beydemir S, Gülçin İ, et al. Effects of low molecular weight plasma inhibitors of rainbow trout (Oncorhynchus mykiss) on human erythrocyte carbonic anhydrase-II isozyme activity in vitro and rat erythrocytes in vivo. J Enzyme Inhib Med Chem 2005;20:35–9.
  • Akıncıoğlu A, Topal M, Gülçin İ, Göksu S. Novel sulphamides and sulphonamides incorporating the tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors. Arch Pharm (Weinheim) 2014;347:68–76.
  • Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995;64:375–401.
  • Montgomery JC, Venta PJ, Eddy RL, et al. Characterization of the human gene for a newly discovered carbonic anhydrase, CA VII, and its localization to chromosome 16. Genomics 1991;11:835–48.
  • Lehtonen J, Shen B, Vihinen M, et al. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem 2004;279:2719–27.
  • Fujikawa-Adachi K, Nishimori I, Taguchi T, Onishi S. Human mitochondrial carbonic anhydrase VB. cDNA cloning, mRNA expression, subcellular localization, and mapping to chromosome x. J Biol Chem 1999;274:21228–33.
  • Murakami H, Sly WS. Purification and characterization of human salivary carbonic anhydrase. J Biol Chem 1987;262:1382–8.
  • Aksu K, Nar M, Tanç M, et al. Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine. Bioorg Med Chem 2013;21:2925–31.
  • Tureci O, Sahin U, Vollmar E, et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA 1998;95:7608–13.
  • Fujikawa-Adachi K, Nishimori I, Taguchi T, Onishi S. Human carbonic anhydrase XIV (CA14): cDNA cloning, mRNA expression, and mapping to chromosome 1. Genomics 1999;61:74–81.
  • Zhu XL, Sly WS. Carbonic anhydrase IV from human lung. Purification, characterization, and comparison with membrane carbonic anhydrase from human kidney. J Biol Chem 1990;265:8795–801.
  • Roblin RO, Clapp JW. The preparation of heterocyclic sulfonamides. J Am Chem Soc 1950;72:4890–2.
  • Miller WH, Dessert AM, Roblin RO. Heterocyclic sulfonamides as carbonic anhydrase ınhibitors. J Am Chem Soc 1950;72:4893–6.
  • Vaughan JR, Eichler JA, Anderson GW. Notes – heterocyclic sulfonamides as carbonic anhydrase ınhibitors. 2-Acylamido- and 2-sulfonamido-1,3,4-thiadiazole-5-sulfonamides. J Org Chem 1956;21:700–1.
  • Young RW, Wood KH, Vaughan JR, Anderson GW. 1,3,4-Thiadiazole- and thiadiazolinesulfonamides as carbonic anhydrase ınhibitors. Synthesis and structural studies. J Am Chem Soc 1956;78:4649–54.
  • Mert S, Alım Z, İşgör MM, et al. The synthesis of novel pyrazole-3,4-dicarboxamides bearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II. Bioorg Chem 2016;68:64–71.
  • Supuran CT, Carbonic anhydrase inhibitors. In: Puscas I, ed. Carbonic anhydrase and modulation of physiologic and pathologic processes in the organism. Timisoara: Helicon; 1994:29–111.
  • Maren TH. Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 1967;47:595–781.
  • Supuran CT, Conroy CW, Maren TH. Carbonic anhydrase inhibitors: synthesis and inhibitory properties of 1,3,4-thiadiazole-2,5-bissulfonamide. Eur J Med Chem 1996;31:843–6.
  • Bayer KH, Baer JE. Physiological basis for the action of newer diuretic agents. Pharmacol Rev 1961;13:517–62.
  • Maren TH. Relations between structure and biological activity of sulfonamides. Annu Rev Pharmacol Toxicol 1976;16:309–27.
  • Mincione F, Menabuoni L, Briganti F, et al. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides – a novel class of intraocular pressure lowering agents. J Enzym Inhib 1998;13:267–84.
  • Sugrue MF. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocul Pharmacol Ther 1996;12:363–76.
  • Jadeja RN, Shah JR, Suresh E, Paul P. Synthesis and structural characterization of some Schiff bases derived from 4-[{(aryl)imino}ethyl]-3-methyl-1-(4′-methylphenyl)-2-pyrazolin-5-one and spectroscopic studies of their Cu(II) complexes. Polyhedron 2004;23:2465–74.
  • Sumalan SL, Casanova J, Alzuet G, et al. Synthesis and characterization of metal(II)-8-quinolinsulfonamidato (sa-) complexes (M = Co, Ni, Cu, and Zn). Crystal structure of [Zn(sa)2(NH3)]NH3 complex. Carbonic anhydrase inhibitory properties. J Inorg Biochem 1996;62:31–9.
  • Supuran CT. Thienothiopyransulfonamides as complexing agents for the preparation of dual carbonic anhydrase inhibitors. Met Based Drugs 1995;2:327–30.
  • Borras V, Cristea T, Supuran CT. Complexes with biologically active ligands. Part 5. Zn(II) and Cd(II) coordination compounds of hydrazine and heterocyclic sulfonamides as inhibitors of the zinc enzyme carbonic anhydrase. Main Group Met Chem 1996;19:339–410.
  • Mincione G, Scozzafava A, Supuran CT. Carbonic anhydrase ınhibitors. Part 46. Inhibition of carbonic anhydrase ısozymes I, II and IV with trifluoromethylsulfonamide derivatives and their zinc(II) and copper(II) complexes. Met Based Drugs 1997;4:27–34.
  • Borràs J, Casanova J, Cristea T, et al. Complexes with biologically active ligands. Part 6. Ni(II) coordination compounds of hydrazine and heterocyclic sulfonamides as ınhibitors of the zinc enzyme carbonic anhydrase. Met Based Drugs 1996;3:143–8.
  • Scozzafava A, Supuran CT. Complexes with biologically active ligands. Part 10. Inhibition of carbonic anhydrase ısozymes I and II with metal complexes of imidazo[2,1-b]-1,3,4-thiadiazole-2 sulfonamide. Met Based Drugs 1997;4:19–26.
  • Büyükkidan N, Büyükkidan B, Bülbül M, et al. Synthesis and characterisation of novel Co(II) complexes of pyrazole carboxylate derivated of sulfonamide as carbonic anhydrase inhibitors. J Pharm Pharmacol 2013;65:363–9.
  • Büyükkidan N, Bülbül M, Kasimoğullari R, Büyükkidan B. Synthesis and characterization of metal complexes of heterocyclic sulfonamide as carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2013;28:311–15.
  • Bülbül M, Kasimoğullari R, Küfrevioğlu OI. Amide derivatives with pyrazole carboxylic acids of 5-amino-1,3,4-thiadiazole 2-sulfonamide as new carbonic anhydrase inhibitors: synthesis and investigation of inhibitory effects. J Enzyme Inhib Med Chem 2008;23:895–900.
  • Arslan B, Nalbantoğlu B, Demir N, et al. A new method for the purification of carbonic anhydrase isozymes by affinity chromatography. Trop J Med Sci 1996;26:163–6.
  • Rickli EE, Ghazanfar SA, Gibbson BH, Edsall JT. Carbonic anhydrases from human erythrocytes. Preparatıon and propertıes of two enzymes. J Biol Chem 1964;239:1065–78.
  • Bradford MM. Determination of sepharose-bound protein with Coomassie brilliant blue G-250. Anal Biochem 1985;151:571–4.
  • Laemmli DK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–5.
  • Wilbur KM, Anderson NG. Electrometric and colorimetric determination of carbonic anhydrase. J Biol Chem 1948;176:147–54.
  • Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–9.
  • Innocenti A, Scozzafava A, Parkkila S, et al. Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates. Bioorg Med Chem Lett 2008;18:2267–71.
  • Landolfi C, Marchetti M, Ciocci G, Milanese C. Development and pharmacological characterization of a modified procedure for the measurement of carbonic anhydrase activity. Pharmacol Toxicol Methods 1997;38:169–72.
  • Bülbül M, Hisar O, Beydemir S, et al. The in vitro and in vivo inhibitory effects of some sulfonamide derivatives on rainbow trout (Oncorhynchus mykiss) erythrocyte carbonic anhydrase activity. J Enzyme Inhib Med Chem 2003;18:371–5.
  • Ciftçi M, Bülbül M, Gül M, et al. Effects of nicotine and vitamin E on carbonic anhydrase activity in some rat tissues in vivo and in vitro. J Enzyme Inhib Med Chem 2005;20:103–8.
  • Hisar O, Beydemir Ş, Bülbül M, Yanık T. Kinetik properties of carbonic anhydrase purified from gills of rainbow trout (Oncorhynchus mykiss). J Appl Anim Res 2006;30:185–8.
  • Winum JY, Cecchi A, Montero JL, et al. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors. Bioorg Med Chem Lett 2005;15:3302–6.
  • Pedregosa JC, Casanova J, Alzuet G, et al. Metal complexes of 5-tertbutyloxycarbonylamido-1,3,4-thiadiazole 2-sulfonamide (B-H2ats), a carbonic anhydrase inhibitor. Synthesis and characterization of the copper(II) complex. Crystal structures of B-H2ats and the [Cu(B-ats)(NH3)2]2 dimer complex. Inorg Chim Acta 1995;123:117–24.
  • Barros-Garcia FJ, Bernalte-Garcia A, Luna-Giles F, et al. Synthesis, characterization and crystal structures of bidentate indazole-thiazine derivative ligand and its cobalt(II) and cadmium (II) metal complexes. Polyhedron 2006;25:52–60.
  • Krillova MV, Da Silva MFCG, Kirillov AM, et al. 3D hydrogen bonded heteronuclear Co-II, Ni-II, Cu-II and Zn-II aqua complexes derived from dipicolinic acid. Inorg Chim Acta 2007;360:506–12.
  • Lever ABP. Inorg Electro Spect. Amsterdam, New York: Elsevier Pub Co. The Netherlands; 1968:420–1.
  • Ajibade PA, Kolawole GA, O’Brien P, et al. Cobalt(II) complexes of the antibiotic sulfadiazine, the X-ray single crystal structure of [Co(C10H9N4O2S)2(CH3OH)2]. Inorg Chim Acta 2006;359:3111–16.
  • Chandra S, Kumar R. Synthesis electrochemistry and spectral studies on cobalt(II) and manganese (II) complexes with 12-,14-,15-, and 18-membered N4, N2O2, N2O2S, N6 donor macrocyclic ligands. Synth React Inorg Met-Org Nano-Met Chem 2005;35:161–70.
  • Bayram E, Şentürk M, Kührevioğlu Oİ, Supuran CT. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem 2008;16:9101–5.
  • Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol Ther 1997;74:1–20.